|
|
||||||||
1 Laboratory, 5 Medicine and 8 Surgery Services, James A. Haley Veterans Hospital, and Departments of 2 Biochemistry and Molecular Biology, 6 Internal Medicine, 7 Physiology and Biophysics, and 3 Surgery, University of South Florida, and 4 University of South Florida Cardiac Hormone Center, Tampa, Florida 33612
| |
ABSTRACT |
|---|
|
|
|---|
Atrial natriuretic peptide (ANP) gene
expression was localized in the rat gastric antrum using
immunohistochemistry and in situ hybridization to mucosal cells
in the lower portion of the antropyloric glands. Colocalization of
immunoreactive ANP, long-acting natriuretic peptide, i.e.,
proANP-(1
30), and serotonin in these cells identified them to be
enterochromaffin cells. Fasting for 72 h in 8-mo-old (adult) rats
produced a significant (P < 0.05) decrease in the levels of
ANP prohormone mRNA, immunoreactive proANP-(1-30) and ANP to
~33% of that of fed rats. Fasting in 1-mo-old rats had no effect on
these parameters. Transcripts for natriuretic peptide receptor subtypes
NPR-A, NPR-B, and NPR-C were found in both mucosa and muscle tissues of
the antrum. ANP, brain natriuretic peptide (BNP), and C-type
natriuretic peptide (CNP) stimulated the production of cGMP in antral
mucosa in vitro with a potency of ANP > BNP >>
CNP, suggesting that these receptors were functional. We conclude that
fasting decreases ANP prohormone mRNA and its gene products,
long-acting natriuretic peptide, and ANP in the antrum of adult rats.
natriuretic peptide receptors; stomach; enterochromaffin cells; reverse transcription-polymerase chain reaction
| |
INTRODUCTION |
|---|
|
|
|---|
ATRIAL NATRIURETIC PEPTIDE (ANP) is a member of a
family of natriuretic peptides that includes brain natriuretic peptide
(BNP), C-type natriuretic peptide (CNP), and long-acting natriuretic peptide [proANP-(1
30)], consisting of the first 30 amino
acids of the ANP prohormone (25). ANP regulates a variety of
physiological functions, including natriuresis, diuresis, and
vasodilation (25). Three types of natriuretic peptide receptors for
ANP, BNP, and CNP have been identified. These are the natriuretic
peptide receptor type A (NPR-A), type B (NPR-B), and type C (NPR-C) (5,
15). NPR-A has guanylate cyclase activity and mediates the biological functions of ANP through the synthesis of cGMP (5). NPR-A
preferentially binds ANP and BNP, but has a low affinity for CNP. The
rank order of the binding affinity and potency for cGMP production by
the NPR-A receptor is ANP > BNP >> CNP (25). NPR-B is similar to NPR-A in that it has an intrinsic guanylate cyclase but has a much
higher affinity for CNP than either ANP or BNP (5). The rank order of
binding affinity and potency for cGMP production by the NPR-B receptor
is CNP >> ANP = BNP (25). The NPR-C receptor has equal affinity for
ANP, BNP, and CNP; lacks an intracellular guanylate cyclase domain; and
functions as a clearance receptor for all three natriuretic peptides
(15).
Although ANP is synthesized primarily in the heart and functions as a
cardiac hormone, the fact that ANP and its receptors are coexpressed in
numerous extracardiac tissues, e.g., lung, thymus, gastrointestinal
(GI) tract, suggests a possible role as a regional regulator acting as
an autocrine and/or paracrine regulatory peptide (5, 14, 25).
Immunoreactive ANP and ANP prohormone mRNA are present in
the GI tract of several species, including rat, guinea pig, and human
(14). We and others (12, 27) demonstrated the presence of
immunoreactive ANP and its prohormone, proANP-(1
126), in extracts of
whole rat stomach. With the use of ribonuclease protection analysis and
RIAs, ANP transcripts and proANP-(1
126), the main storage form of ANP
in the heart, were found predominantly in the proximal stomach and antrum (12). However, the cells synthesizing ANP in gastric tissues
have not been identified. Very little is known about the expression and
function of NPRs in the stomach (14). The aims of the present study
were to 1) identify the antral mucosal cells that synthesize
ANP, 2) examine the regulation of antral ANP prohormone gene
expression by feeding and fasting, and 3) determine if
functional ANP receptors are coexpressed in the antrum.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Animals. Male Sprague-Dawley rats were received at 3 wk (100-125 g) and 31 wk (450-500 g; Harlan Sprague Dawley, Indianapolis, IN) and were maintained with free access to water and standard laboratory rat chow for 7 days. Animals in both age groups were randomized into two groups. One group was fasted for 72 h with free access to water and the second group was allowed free access to both food and water for 72 h. All animals were killed by decapitation. These studies were approved by the Institutional Animal Care and Use Committee of the University of South Florida in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
RNA extraction. Immediately after death, cardiac, kidney, lung,
liver, spleen, and stomach tissues were surgically excised, rinsed in
sterile Hanks' balanced salt solution (HBSS), then total RNA was
isolated using RNAzol B (Tel-Test, Friendswood, TX), as described
previously (12). Polyadenylated [poly(A)+] RNA
was purified by oligo(deoxythymidine)-cellulose column
chromatography (Collaborative Research, Bedford, MA). Because the rat
stomach demonstrates a heterogeneous structure displaying significant regional differences in structure and function, we separated the stomach into three regions in our analyses: the proximal or cardia region, the midregion or fundus containing the oxyntic mucosa, and the
distal or antrum region (Fig. 1). Mucosa
and muscle layers of the antrum were prepared by blunt dissection in
cold sterile HBSS. The concentration of RNA isolated was measured by
ultraviolet spectrophotometry, and the quality of the RNA was verified
by agarose gel electrophoresis and ethidium bromide staining.
|
Northern blot and ribonuclease protection analyses. For
Northern blot analyses, total RNA (20 µg) or poly(A)+ (10 µg) samples were denatured, separated on 1.2% agarose-formaldehyde gels, transferred to Hybond N+ nylon membranes (Amersham
Life Science, Arlington Heights, IL), and then the membranes were baked
at 80°C for 2 h. Prehybridization was for 1 h at 45°C in
Hybrisol I (Oncor, Gaithersburg, MD). For detection of gastrin mRNA,
membranes were hybridized overnight at 60°C in fresh Hybrisol I
containing 106 cpm/ml of rat gastrin cRNA probe. A
[
-32P]UTP-labeled 220-bp cRNA probe
complementary to rat gastrin mRNA was synthesized using SP6 RNA
polymerase transcribed from rat gastrin cDNA (generously provided by
Dr. Stephen J. Brand, Massachusetts General Hospital, Boston, MA) in
pGEM 4z linearized with Pvu II (9). Membranes were
washed in 2× SSC, containing 0.1% SDS (1× SSC = 0.15 M
NaCl and 0.015 M citrate) at 24°C for 15 min and then 3 × 20 min at 60°C in 0.1× SSC containing 0.1% SDS (9). Hybridization probes for NPR-A, NPR-B (generous gifts from Dr. David
Garbers, Howard Hughes Medical Institute, University of Texas, Dallas,
TX), and NPR-C (generous gift from Dr. David Lowe, Genentech, San
Francisco, CA) were full-length gel-purified rat cDNAs and were labeled
by random priming with [
-32P]deoxy-CTP
(Promega, Madison, WI) (4, 7, 20). Hybridization and washes were
performed as described previously (4, 7, 12). Autoradiograms were
obtained from the membranes and were quantified by video densitometry
with a UVP GDS8000 gel documentation system (UVP, Upland, CA), using
one-dimensional video densitometry software. Gastrin mRNA was
normalized to the relative amounts of ethidium bromide-stained 28S
rRNA. Normalization of NPR mRNA signals was with signals obtained after
hybridization with a 1.0-kb glyceraldehyde-3 phosphate dehydrogenase
probe (Clonetech Laboratories, Palo Alto, CA). Ribonuclease protection
analysis for rat ANP was as described previously (12). Briefly, an
[
-32P]UTP-labeled 278-bp cRNA probe
complementary to rat ANP mRNA (31) was synthesized using T7 RNA
polymerase transcribed from rat ANP cDNA (generously provided by Dr.
David G. Gardner, University of California, San Francisco, CA) in pGEM
4z. A 132-bp
-actin probe, synthesized from a template
containing a 249-bp fragment of the
-actin gene (Ambion, Austin,
TX), was included in the hybridization reactions as an internal
control. Total RNA (5-40 µg) and gel-purified probes were
denatured, allowed to hybridize overnight at 45°C, then digested
with RNase One (Promega, Madison, WI). Protected fragments were
precipitated and then fractionated on a 6% denaturing polyacrylamide
gel and analyzed by autoradiography. Autoradiographic signals were
quantified by video densitometry as described above and normalized to
the relative amounts of
-actin.
RT-PCR. Except where designated, all reagents used for RT-PCR
were purchased from Life Technologies (Gaithersburg, MD). With the use
of 20 µg of total RNA, single-stranded cDNA was synthesized in a
20-µl reaction mixture containing 1× first strand buffer (50 mM
Tris · HCl, pH 8.3, 75 mM KCl, 3 mM
MgCl2), 10 mM dithiothreitol, 0.5 mM dNTP, 40 U RNasin
(Promega, Madison, WI), 0.5 µg
oligo(deoxythymidine)12
18 primer
and 200 U Superscript II RT. The reaction was incubated for 15 min at
25°C, then for 50 min at 42°C, and then heated to 70°C for
15 min. After cooling to 4°C, 3 U of RNase H was added and the
reaction mixture was incubated for 20 min at 37°C. In all cases,
the authenticity of the PCR products was confirmed by hybridization to
gene-specific cDNA probes and optimization of amplification conditions
was performed using a pool of rat antrum cDNA (data not shown). Each
cDNA-primer combination was optimized for the number of thermocycles
used and the starting cDNA concentration to ensure that synthesis
remained in the exponential phase. Each multiplex PCR reaction mixture
contained varying amounts of cDNA depending upon the mRNA to be
amplified, 20 pmol of each primer in 50 µl of 1× first strand
buffer, 2.5 U Taq polymerase, and 0.4 mM dNTP. Sequences for
rat ANP, NPR-A, NPR-B, NPR-C, and
2-microglobulin
(
-MG) were obtained from GenBank and used to design primers. Primers
for ANP, NPR-A, NPR-B, NPR-C, and
-MG were prepared in the DNA
synthesis facility of the Interdisciplinary Center for Biotechnology
Research, University of Florida, Gainesville, FL. The sequences and
positions of these primers are as follows: ANP: sense
5'-ACGCCAGCATGAGCTCCTTC-3' (57-76) and antisense
5'-ATCTTCGGTACCGGAAGCTG-3' (502-521) (31); NPR-A:
sense 5'-GGATGCCTTCAGGAATCTGA-3' (959-978) and
antisense 5'-TGACACAGCCATTAGCTCCT-3' (1507-1526) (4);
NPR-B: sense 5'-AGCAACCTCAGTGTGCAACA-3' (652-671) and
antisense 5'-TGAAAGTCGCCAGACTCCAA-3' (1270-1289)
(20); NPR-C: sense 5'-CTTCTATGGAGATGGCT-3'
(885-902) and antisense 5'-TGCTTTGCAAGGAGAGC-3'
(1410-1426) (7);
-MG: sense
5'-CTCCCCAAATTCAAGTGTACTCTCG-3' (78-102) and
antisense 5'-GAGTGACGTGTTTAACTCTGCAAGC-3' (302-326) (17). The program for each gene was as follows: ANP, 94°C (add Taq polymerase) for 3 min, 60°C for 5 min, 72°C for 1 min, 94°C for 1 min, 60°C for 1.5 min
for 28 cycles; NPR-A and NPR-B, 96°C for 5 min, 60°C for 1.5 min, 72°C for 1.5 min, 80°C (add Taq polymerase) for 1 min, 93°C for 1 min, 60°C for 1.5 min, 72°C for 2 min for
30 cycles; NPR-C, 96°C for 5 min, 57°C for 1.5 min, 72°C
for 2 min, 80°C for 1 min (add Taq polymerase), 93°C
for 1 min, 57°C for 1.5 min, 72°C for 2 min for 30 cycles. To
reduce the competitive interference in the multiplex PCR by the
internal control
-MG and to ensure its amplification was exponential, we used the primer-dropping method described by Wong et
al. (29). Primers for
-MG were added after 10 cycles for ANP, NPR-A,
and NPR-B and after 15 cycles for NPR-C. PCR products were analyzed by
ethidium bromide-stained agarose gel electrophoresis. Comparative
quantitation was performed by video densitometry as described above and
normalized to
-MG.
Immunocytochemistry. Freshly excised atria and antrum were
fixed in Zamboni's fixative and embedded in paraffin. Sections (4-6 µm) were deparaffinated, rehydrated, and treated with 0.3% hydrogen peroxide in methanol for 30 min at 25°C to block
endogenous peroxidase activity. Sections were then incubated for 20 min
at 25°C with dilution buffer (PBS containing 0.3% Triton X-100 and 4% normal goat serum). Sections were incubated at 4°C for
16-18 h with primary antibody: rabbit anti-rat ANP, 1:250 (IHC
9103, Peninsula Laboratories, Belmont, CA); rabbit anti-human
proANP-(1
30), 1:500 (IHC 9129, Peninsula Laboratories); or rabbit
anti-serotonin, 1:1,000 (S-5545, Sigma Chemical, St. Louis, MO). The
ANP antiserum recognizes the 28-amino acid carboxy terminus of the
prohormone of ANP [proANP-(99
126)] as well as ANP. The
proANP-(1
30) antiserum recognizes the 30-amino acid fragment of the
amino terminus of the ANP prohormone and exhibits no cross-reactivity
with the carboxy terminus of the prohormone or ANP (11). After washing
twice with PBS for 5 min, tissue sections were incubated at 37°C
for 1 h with 3 µg/ml biotinylated goat anti-rabbit antibody (Vector Laboratories, Burlingame, CA) in the dilution buffer and then washed
and incubated at 37°C for 1 h with a streptavidin-biotin complex
reagent containing horseradish peroxidase (Vector Laboratories) in
dilution buffer. After washing two times in PBS for 5 min, sections
were incubated with metal-enhanced 3,3-diaminobenzidene solution
(Pierce, Rockford, IL) for 10-12 min. Sections were washed in
distilled water and counterstained with Mayer's hematoxylin. Control
sections incubated with normal rabbit serum instead of primary antibody
or primary antibody preabsorbed with excess immunogen (10 µg/ml)
exhibited no staining.
In situ hybridization. The nonradioactive detection method was performed using a commercial assay (RPN 3300, Amersham Life Science). In brief, cryostat (12 µm) sections were fixed with 4% paraformaldehyde, treated with 0.1% Triton X-100, and incubated with proteinase K (100 µg/ml) at 37°C for 20 min. Sections were incubated with glycine (2 mg/ml) for 5 min at 25°C, acetic acid (20%) at 4°C for 15 s, washed in PBS, and then dehydrated. The preparation of the ANP cRNA probes was similar to the method used in ribonuclease protection analysis, except that fluorescein-11 UTP was used rather than [32P]UTP. Hybridization was performed at 55°C overnight with 1.2 µg/ml fluorescein-labeled antisense or sense ANP cRNA. The sections were washed in decreasing concentrations of SSC, terminating with a final concentration of 0.2× at 55°C, treated with ribonuclease A, washed in 100 mM Tris · HCl, pH 7.5, 400 mM NaCl, incubated with blocking solution, and then incubated with an antifluorescein alkaline phosphatase-conjugated antibody for 60 min at 25°C. Hybridization signals were visualized by nitro blue tetrazolium-5-bromo-4-chloro-3-indolyl phosphate chromogen.
Antral peptide extraction and RIAs. Extracts of antrum were
prepared by boiling washed and preweighed tissues for 10 min in 10 vol
of 1 N acetic acid containing 0.1 mM phenylmethylsulfonyl fluoride, as
described in detail previously (12). Gastrin (13), ANP, and
proANP-(1
30) (11) concentrations in the supernatants were determined
by specific RIAs as previously described. Gastrin antiserum 3021178 recognizes all amidated carboxy terminal molecular species (13). ANP
antiserum (Peninsula Laboratories) recognizes the carboxy terminal
amino acids 99-126 of the prohormone, i.e., ANP (15).
ProANP(1
30) antiserum (Peninsula Laboratories) recognizes the amino
terminal amino acids 1-30 of the prohormone (11). Both antisera
cross-react with the complete ANP prohormone within tissues, but
neither recognized the prohormone within the circulation (12).
cGMP production in antral mucosa. The effects of rat ANP, BNP,
CNP, and analog C-atrial natriuretic factor (C-ANF) on
cGMP production in antral mucosa incubated in vitro were
as described previously (23). C-ANF is rat
(des-Gln18,Ser19,
Gly20,Leu21,Gly22)-ANF, a specific
agonist for NPR-C. The muscle layer was separated from the antral
mucosa by blunt dissection, and then the mucosa was cut into small
segments (1-2 mm3). Antral mucosa segments (3 or 4)
were incubated in tubes containing 1 ml of Krebs-Ringer bicarbonate
medium supplemented with amino acids and vitamins and gassed with 95%
O2 and 5% CO2. Segments were preincubated for
30 min at 37°C in 1 ml of Krebs-Ringer bicarbonate medium
containing 500 µM IBMX and 1 µM phosphoramidon. ANP, BNP, CNP, or
C-ANF was added to each tube in a final concentration of from
10
10 to
10
6 M and incubated for an additional 30 min at 37°C. In some experiments, the explants were pretreated with
10
5 M of the NPR-A antagonist anantin
(28) (Bachem, King of Prussia, PA) for 5 min before the addition of
10
6 M ANP or BNP. After the incubation,
tissue segments were collected by centrifugation at 600 g and
then were homogenized in 0.1 N HCl. The homogenate was centrifuged at
30,000 g for 10 min at 4°C, and then the supernatant was
extracted with water-saturated ether three times and the levels of cGMP
were measured by RIA after acetylation (Amersham Life Science). The
detection limit of the assay was 0.150 pmol/tube, and the
EC50 was 1.85 pmol/tube. The tissue pellet was resuspended
in 1 N NaOH, and protein was measured by the Bradford method (BioRad
Laboratories, Hercules, CA) with bovine serum albumin as the standard.
Statistics. Data are presented as means ± SE. Unpaired Student's t-test was used to compare between two experimental groups. Significance of differences between more than two groups was analyzed by ANOVA, followed by Bonferroni correction of t-tests for multiple comparisons against the same control group. Differences were considered significant at P < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Expression of ANP prohormone mRNA in the stomach. Previously we
used ribonuclease protection analysis to detect and semiquantitate ANP
prohormone mRNA in rat gastrointestinal tract (12). To increase sensitivity, we developed and used an RT-PCR assay for detection of ANP
prohormone mRNA in rat tissues. The relative difference in the signal
for the cDNA produced with exon primers was nearly identical to that
determined by ribonuclease protection analysis of the same samples
(Fig. 2). The proximal stomach and antrum had two- and threefold higher levels of ANP transcripts than the fundus, respectively (Fig. 2).
|
Identification of ANP-expressing cells in antrum. We previously
reported the presence of the complete ANP prohormone in acid extracts
of rat antrum using two separate RIAs that employ antisera directed to
opposite ends of the proANP-(1
126) molecule (12). When these same two
antisera, i.e., antiserum to amino acids 1-30 of the prohormone
(long-acting natriuretic peptide) and antiserum to amino acids
99-126 of the prohormone [proANP-(99
126) or ANP], were used to immunostain rat atria, identical intense positive staining
of atrial cardiocytes was observed (Fig. 3,
A and B). In the present comparative study,
immunostaining of rat antrum with both antisera produced an
indistinguishable pattern of immunopositivity (Fig. 3, D,
E, G, and H), suggesting that the ANP
prohormone is present in the antral mucosa. The immunoreactive ANP- and
proANP-(1
30)-containing cells were found in low numbers predominantly
in the lower third of the antropyloric glands. The morphology of the
individual proANP-immunoreactive cells was variable, exhibiting round,
pyramidal, and flask shapes. The general epithelial morphology of these
cells was typically endocrine in appearance, with a connection to the
antral lumen and the majority of immunoreactivity localized to the
basal portion of the cell (Fig. 3H). Because of the likely
endocrine nature of the cell and with the knowledge that ANP is
expressed in adrenal chromaffin cells as well as enterochromaffin (EC)
cells in human colon, serial sections were stained with antisera to ANP
and serotonin (marker for EC cells) (10, 18). In consecutive serial
sections immunostained for ANP and serotonin, a very similar pattern of positive staining was observed (Fig. 3, J and K). These
results suggest that it is the EC cells in the antral mucosa that
synthesize ANP. No positive staining for immunoreactive ANP or
proANP-(1
30) was detected in cells within the lamina propria,
submucosa, smooth muscle, or ganglion cells. Specific staining was
absent when nonimmune rabbit serum was substituted for proANP antiserum
(Fig. 3C) or when the antisera were preabsorbed with their
respective peptide immunogens (Fig. 3, F and I).
|
The localization of ANP-synthesizing cells was confirmed by
colorimetric in situ hybridization. The specificity of
hybridization produced by the proANP antisense cRNA probe was evaluated
by incubation with cyrosections of rat atria. Similar to the pattern
observed after immunohistochemical staining, the antisense probe
produced intense paranuclear cytoplasmic staining of atrial myocytes
(Fig. 4A). No signal was detected
when the ANP sense cRNA probe was used (Fig. 4B). In antrum,
the ANP antisense probe produced intense cytoplasmic hybridization
signals primarily in cells scattered throughout the basal portion of
the glands (Fig. 4C). These cells, similar to the
immunoreactive proANP-containing cells, were few in number and
exhibited considerable variation in their morphology. Occasionally,
weak positive staining was observed within smooth muscle cells, but no
staining was detected in lamina propria, submucosa, or ganglion cells.
Staining specificity was confirmed by the absence of any positive
signal when the sense probe was substituted for the antisense cRNA
(Fig. 4D).
|
Effect of fasting on antral ANP prohormone gene expression. To
determine whether the expression of ANP in stomach antrum is altered in
response to altered gastric luminal environment, we examined the
steady-state ANP prohormone mRNA levels in antrums from rats that were
allowed free access to food and/or fasted for 72 h (food deprived).
Furthermore, to investigate the effect of age on the ANP prohormone
gene response to fasting, we compared the effects of fasting to feeding
ad libitum in young (1 mo) and adult (8 mo) rats. To monitor
the endocrine status of the antrum, we measured the steady-state levels
of gastrin mRNA and the concentration of immunoreactive gastrin in the
antrums of fed and food-deprived animals. In accordance with previous
findings (30), both the abundance of gastrin mRNA and the concentration
of immunoreactive gastrin were significantly decreased in antrums of
animals after 72 h of fasting (Fig. 5).
Fasting reduced antral gastrin levels to approximately one-third of
that observed in fed animals (1 mo, 29%, P < 0.05; 8 mo,
38%, P < 0.05) (Table 1). Mean
antral gastrin concentration decreased significantly to 23% in
1-mo-old rats and 22% in 8-mo-old rats. There were no significant
differences in the antral levels of either gastrin mRNA or
immunoreactive gastrin between 1- and 8-mo-old rats.
|
|
When 1-mo-old rats were fasted for 72 h, the abundance of ANP
prohormone mRNA was not significantly altered compared with rats fed ad
libitum (Fig. 6). Food deprivation did not
significantly alter the antral concentrations of immunoreactive ANP or
proANP-(1
30) in 1-mo-old rats (Table 1). In contrast, in 8-mo-old
rats, ANP mRNA abundance was significantly (P < 0.05)
depressed to 33% the level in fed rats. Food deprivation resulted in
similar decreases in antral concentrations of immunoreactive ANP and
proANP-(1
30) to 36 and 38% of fed values, respectively (Table 1).
Thus food-deprivation in older adult rats produced a significant
decrease in antral ANP gene products similar in magnitude to that
observed for gastrin.
|
NPR subtype gene expression in stomach. To examine the
distribution of NPR subtype mRNAs in stomach, we devised a sensitive RT-PCR assay specific for each receptor subtype. Because all primer pairs were designed to span an intron, amplification from cDNA vs.
genomic DNA sequences was readily distinguishable by the predicted PCR
product. NPR-A (575 bp), NPR-B (645 bp), and NPR-C (541 bp) primers
produced a single PCR product of the expected size (Fig. 7A). No PCR product was detected in
the absence of cDNA (data not shown). To validate the NPR RT-PCR
assays, we examined a variety of rat tissues that had been previously
reported to express NPRs. Figure 7 shows a representative result from
RT-PCR assay of total RNA extracted from ventricle, kidney, lung,
liver, spleen, and the three anatomic regions of the rat stomach.
Transcripts for NPR-A, NPR-B, and NPR-C were found in all tissues
assayed, confirming the reports that the NPR genes are widely expressed
in the rat (5, 22). It is important to note in this figure that more natriuretic peptide receptor NPR-A and NPR-B transcripts were present
in the stomach than in the kidney, liver, lung, or spleen. Interestingly, transcripts for all three receptor subtypes were detected in each of the histologically distinct regions of the stomach.
The distribution of NPR transcripts in antrum was further examined
using total RNA extracted from mucosa and muscle layers. Figure 7,
B and C, demonstrate that NPR-A, NPR-B, and NPR-C genes are expressed in both tissue layers of the antrum. Transcripts for all
three NPRs were twice as abundant in smooth muscle than in mucosa.
Within both tissue layers the order of relative abundance was NPR-A = NPR-B > NPR-C.
|
To ascertain the nature of the NPR mRNA species in these tissues, we
examined poly(A)+ RNA for NPR transcripts by Northern blot
analysis. In confirmation of the results from RT-PCR analysis,
transcripts for all three NPR subtypes were detected by Northern blot
analysis in both antral mucosa and smooth muscle tissues (Fig.
8). Both NPR-A and NPR-B transcripts were
detected at ~4.2 kb, a size similar to that observed in other tissues
(1, 4, 20). NPR-C hybridization signals were multiple, with bands
appearing at 9.0-2.0 kb. A similar pattern of
multiple bands for NPR-C has been reported in other tissues (1, 7).
|
Stimulation of cGMP in rat antral mucosa by natriuretic peptides.
The existence of functional NPR-A and NPR-B receptors in antral
mucosa, i.e., within the immediate vicinity of EC cells, has not been
demonstrated previously. To determine if the NPRs are expressed at
functionally relevant levels in antral mucosa, the ability of ANP, BNP,
and CNP to stimulate cGMP production was examined in antral mucosa in
vitro. As shown in Fig. 9A, ANP, BNP, and CNP induced a concentration-dependent accumulation of intracellular cGMP, with an order of potency of ANP > BNP >> CNP. At 10
6 M, ANP and BNP increased the
intracellular levels of cGMP approximately fourfold, from an average
control level of 109 ± 24 to 467 ± 28 and 378 ± 30 fmol/mg,
respectively (P < 0.01). In contrast, CNP at the same
concentration produced a significant, but lower, twofold increase (235 ± 23 fmol/mg; P < 0.05) in cGMP levels compared with
controls. Maximal intracellular cGMP levels were achieved within 5 min
after exposure to ANP, BNP, and CNP (data not shown). As expected, the
NPR-C-specific agonist C-ANF had no effect on cGMP levels at all
concentrations tested. These findings are consistent with the presence
of both functional NPR-A receptors activated by ANP and BNP and NPR-B
receptors activated by CNP.
|
To confirm that the NPR-A receptor was mediating the effects of ANP and BNP in the antral mucosa, we determined the effect of the selective NPR-A antagonist, anantin, on the stimulation of cGMP production by both ANP and BNP (28). Anantin is a functional NPR-A antagonist and has no agonist activity (28). As shown in Fig. 9B, anantin had no significant effect on basal cGMP production. Anantin, however, significantly blunted both ANP- and BNP-stimulated cGMP accumulation by >60%. This suggests that ANP and BNP are mediating cGMP production in these preparations via the NPR-A receptor. These results are consistent with the RT-PCR and Northern blot data of the present study and indicate the presence of both functional NPR-A and NPR-B receptors in antral mucosa.
| |
DISCUSSION |
|---|
|
|
|---|
We and others (12, 27) have provided evidence that the ANP gene may be expressed in the rat stomach. In the present study, we have demonstrated the presence of varying levels of ANP prohormone mRNA in extracts of the three histologically distinct regions (cardia, fundus, antrum) of the rat stomach. This selective distribution, with antrum and cardia having much higher levels than the fundus, suggests that ANP may have tissue-specific functions within the stomach.
Our earlier findings that demonstrated that the rat antrum contains
proANP-(1
126) coupled with the present results that show similar
immunostaining patterns are produced when antibodies are directed to
either the amino or carboxy terminus of proANP-(1
126) support the
idea that ANP is stored within antral mucosal cells as its prohormone.
This suggests that the posttranslational processing of preproANP in
antral EC cells may be similar to that found in other ANP-synthesizing
cells, e.g., human colon EC cells, adrenal chromaffin cells, and
cardiomyocytes in which the ANP prohormone is the main storage form
within the cell (10, 18, 25). Due to the relative abundance of both ANP
prohormone mRNA and its gene product proANP-(1
126) within the antrum,
we sought to identify the cells within this region that synthesize this
prohormone. Using immunohistochemical staining with two antibodies
directed to different epitopes of the ANP prohormone and in situ
hybridization, we identified a subset of epithelial cells within the
basal glands of the antral mucosa that express the ANP prohormone. That
these cells were endocrine cells was suggested by their location within the lower third of the antral glands, their relatively low density, and
their morphological appearance. The colocalization of ANP and serotonin
in these cells suggests that the ANP gene is expressed in this subset
of EC cells. This is consistent with the reports that adrenal
chromaffin cells and EC cells in human colon synthesize ANP (10, 18).
Immunoreactive ANP has been reported in immune-type cells in lymphatic
nodules in the lamina propria and the submucosa in guinea pig and rat
intestine (14). In the human stomach, on the other hand, immunoreactive
ANP has not been found in the lamina propria or submucosa (6). Similar
to the results of Ehrenreich et al. (6) for human stomach, we did not
detect any immunopositive staining for ANP or long-acting natriuretic
peptide, i.e., proANP-(1
30) in the lamina propria or submucosa in the
stomach antrum of the rat. We also did not detect ANP prohormone mRNA
by in situ hybridization in these areas.
EC cells are an abundant type of enteroendocrine cell that contain serotonin and occur throughout the GI tract (21). On the basis of differences in the ultrastructural appearance of the secretory granules, it has been suggested that EC cells are comprised of several subpopulations of endocrine cells, each of which manufactures and stores different peptides (21). EC cells are typically of the open-type enteroendocrine cell, with a large basolateral compartment in contact with the basal lamina and a narrow apical process that allows access to the lumen (21). Results from our present immunohistochemical studies demonstrate that at least some of the ANP-containing cells in the antral mucosa are exposed to both basal lamina and lumen (Fig. 3H), similar to the known subset of EC cells (21). Interestingly, after an increase in intraluminal pressure, duodenal EC cells release serotonin into both interstitial and luminal compartments (8). This observation may be pertinent to ANP as it may also be released into the lumen of the stomach secondary to a rise in intraluminal pressure, because the ANP-containing EC cells extend into the gastric lumen and it is known that a small increase (3 mmHg) in intra-atrial pressure will release ANP (25).
Our results are in agreement and extend the observations of Li and Goy (16) and Rambotti et al. (19) that demonstrate the presence of NPR-A and NPR-B transcripts in extracts of gastric fundus and localize natriuretic peptide-induced cGMP production to parietal cells, mucus secreting cells in the fundus, and pyloric glands, as well as gastric smooth muscle cells. Because ANP is known to stimulate gastric acid secretion and relax gastric smooth muscle (14) these findings suggest that these effects of ANP may be direct. Further evidence for functional receptors in gastric tissues comes from the reports that ANP stimulates the production of cGMP in guinea pig chief cells and that ANP induces the relaxation of cultured gastric smooth muscle cells (2, 3). Rambotti et al. (19) demonstrated the presence of ANP-induced guanylate cyclase activity on both apical and basolateral surfaces of mucosal cells within the pyloric glands of rat stomach, consistent with our suggestion that ANP released locally into the gastric lumen could target these luminally directed receptors. This suggests that ANP may help control a "negative feedback" system within the stomach of increasing acid secretion and simultaneously enhance mucus production to protect the lining of the stomach from the effects of acid. This would provide for a regulatory mechanism to ensure that the acid produced after a meal does not injure the mucosal surface of the stomach.
A very interesting finding of the present investigation was that fasting decreases ANP prohormone gene expression in adult rats. The present data are the first evidence that any change in the diet can alter ANP gene expression in the GI tract. The decrease in ANP gene expression with fasting is what one would expect to occur if the products of this gene, i.e., ANP and long-acting natriuretic peptide are important in helping to regulate fluid fluxes and peristalsis in the GI tract, as has been suggested previously (25). If food is not reaching the stomach, one would expect an increase in fluid absorption and decreased peristalsis if the stomach were helping to control distal GI tract function via its ANP hormonal system. Because the stomach is where digestion begins in the GI tract, one ideally would like to have a hormonal system based in the stomach that could communicate to the rest of the GI tract when to decrease its function when no food is entering the GI tract. The present investigation suggests that this is exactly what is occurring. Thus, with fasting, the expression of the ANP is markedly diminished, resulting in a marked decrease in the gene products, ANP and long-acting natriuretic peptide, that are available to inform the rest of the GI tract to decrease peristalsis and allow an increase in fluid absorption. With respect to this point, after eating, ANP increases 45% in the circulation (24), suggesting that feeding also regulates the release of ANPs. The reason why ANP prohormone gene expression was not suppressed by fasting for 72 h in 1-mo-old rats is not known at present, but suggests that the hormonal system is not fully developed in very young rats. The finding that the decrease in ANP expression in the antrum of food-deprived rats parallels the decrease in gastrin gene expression is also intriguing. Age-dependent alterations in tissue concentrations, secretion rate, and response to luminal stimuli have been documented for other gastric regulatory peptides (14).
In conclusion, our results demonstrate that immunoreactive ANP, long-acting natriuretic peptide, and functional NPR-A receptors coexist in rat antral mucosa, suggesting a regional gastric ANP system whose gene expression and gene products are modulated by fasting.
Perspectives
The ability to decrease ANP gene expression and gene products in the stomach by fasting, with the corollary that these gene products increase in the circulation (24) and their excretion into urine increases (26) with food intake, suggests that distension or stretch of the stomach may be important to physiological regulation of the natriuretic peptide system within the GI tract similar to stretch of the heart being important for regulation of the same gene within the heart (14, 25). The present findings lead one to speculate that stretch throughout the GI tract may be an important regulator of this natriuretic peptide system. Because ANPs are present within the small intestine and colon (12, 14), as well as the stomach, as food moves through the small intestine and colon and, thereby, stretches the small intestine and colon, this may 1) stimulate ANP prohormone gene expression and/or 2) enhance release of its gene products to assist in the coordination of fluid homeostasis and motility throughout the GI tract.The finding of the present investigation that ANP was localized near the basolateral surface of the EC cells suggests a mechanism for the previous observation that ANP increases in the circulation secondary to food intake. This basolateral plasma membrane is juxtaposed to capillaries via which atrial peptides could enter the circulation from the stomach.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. Gabriel M. Makhlouf and Mitchel L. Schubert for critical reading of the manuscript.
| |
FOOTNOTES |
|---|
This work was supported in part by grants-in-aid from the American Heart Association, Florida Affiliate (AHA9601460 to W. R. Gower, Jr., AHA9701703 to J. R. Dietz, AHA9701727 to D. L. Vesely), Department of Veterans Affairs (to D. L. Vesely), and the Eleanor Schultze Memorial Fund (to W. R. Gower, Jr.).
Portions of this work were published previously in abstract form (Gastroenterology 108: A971, 1995; Gastroenterology 110: A1074, 1996).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: W. R. Gower, Jr., James A. Haley VA Hospital, Research Service (151), 13000 Bruce B. Downs Blvd., Tampa, Florida 33612 (E-mail: wgower{at}hsc.usf.edu).
Received 2 July 1999; accepted in final form 24 September 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Cao, L.,
and
D. G. Gardner.
Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts.
Hypertension
25:
227-234,
1995
2.
Cherner, J. A.,
G. Singh,
and
L. Naik.
Atrial natriuretic factor activates membrane-bound guanylate cyclase of chief cells.
Life Sci.
47:
669-677,
1990[Web of Science][Medline].
3.
Chijiiwa, Y.,
T. Kabemura,
T. Misawa,
O. Kawakami,
and
H. Nawata.
Direct inhibitory effect of calcitonin gene-related peptide and atrial natriuretic peptide on gastric smooth muscle cells via different mechanisms.
Life Sci.
50:
1615-1623,
1992[Web of Science][Medline].
4.
Chinkers, M.,
D. L. Garbers,
M. S. Chang,
D. G. Lowe,
H. Chin,
D. V. Goeddel,
and
S. Schultz.
A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor.
Nature
338:
78-83,
1989[Medline].
5.
Drewett, J. G.,
and
D. L. Garbers.
The family of guanylyl cyclase receptors and their ligands.
Endocrin. Rev.
15:
135-162,
1994
6.
Ehrenreich, H.,
F. Sinowatz,
R. Schulz,
R. M. Arendt,
and
F. D. Goebel.
Immunoreactive atrial natriuretic peptide (ANP) in endoscopic biopsies of human gastrointestinal tract.
Res. Exp. Med.
189:
421-425,
1989[Medline].
7.
Engel, A. M.,
J. R. Schoenfeld,
and
D. G. Lowe.
A single residue determines the distinct pharmacology of rat and human natriuretic peptide receptor-C.
J. Biol. Chem.
269:
17005-17008,
1994
8.
Fujimiya, M.,
K. Okumiya,
and
A. Kuwahara.
Immunoelectron microscopic study of the luminal release of serotonin from rat enterochromaffin cells induced by high intraluminal pressure.
Histochem. Cell Biol.
108:
105-113,
1997[Web of Science][Medline].
9.
Fuller, P. J.,
D. L. Stone,
and
S. J. Brand.
Molecular cloning and sequencing of a rat preprogastrin complementary deoxyribonucleic acid.
Mol. Endocrinol.
1:
306-311,
1987
10.
Gerbes, A. L.,
W. Nathrath,
M. Cantin,
and
H. Deneche.
Presence of atrial natriuretic factor prohormone in enterochromaffin cells of the human large intestine.
Gastroenterology
101:
424-429,
1991[Web of Science][Medline].
11.
Gower, W. R., Jr.,
S. Chiou,
K. A. Skolnick,
and
D. L. Vesely.
Molecular forms of circulating atrial natriuretic peptides in human plasma and their metabolites.
Peptides
15:
861-867,
1994[Web of Science][Medline].
12.
Gower, W. R., Jr.,
J. R. Dietz,
D. L. Vesely,
C. L. Finley,
K. A. Skolnick,
P. J. Fabri,
D. R. Cooper,
and
C. E. Chalfant.
Atrial natriuretic peptide gene expression in the rat gastrointestinal tract.
Biochem. Biophys. Res. Commun.
202:
562-570,
1994[Web of Science][Medline].
13.
Gower, W. R., Jr.,
E. C. Ellison,
T. H. Knierim,
E. A. Elkhammas,
T. M. O'Dorisio,
and
P. J. Fabri.
Gastrinoma in vitro: morphological and physiological studies of primary cell cultures.
Gastroenterology
98:
936-954,
1990[Web of Science][Medline].
14.
Gower, W. R., Jr.,
and
J. P. Skvorak.
The gastrointestinal natriuretic peptide system: a regional system with tissue-specific and vascular components.
In: Atrial Natriuretic Peptides, edited by D. L. Vesely. Trivandrum, India: Research Signpost, 1997, p. 139-150.
15.
Levin, E. R.
Natriuretic peptide C-receptor: more than a clearance receptor.
Am. J. Physiol. Endocrinol. Metab.
264:
E483-E489,
1993
16.
Li, Z.,
and
M. F. Goy.
Peptide-regulated guanylate cyclase pathways in rat colon: in situ localization of GCA, GCC, and guanylin mRNA.
Am. J. Physiol. Gastrointest. Liver Physiol.
265:
G394-G402,
1993
17.
Mauxion, F.,
and
M. Kress.
Nucleotide sequence of rat beta 2-microglobulin cDNA.
Nucleic Acids Res.
15:
7638,
1987
18.
Nguyen, T. T.,
K. Babinski,
H. Ong,
and
A. De Lean.
Differential regulation of natriuretic peptide biosynthesis in bovine adrenal chromaffin cells.
Peptides
11:
973-978,
1990[Web of Science][Medline].
19.
Rambotti, M. G.,
I. Giambanco,
and
A. Spreca.
Detection of guanylate cyclases A and B stimulated by natriuretic peptides in gastrointestinal tract of rat.
Histochemical J.
29:
117-126,
1996.
20.
Schulz, S.,
S. Singh,
R. A. Bellet,
G. Singh,
D. J. Tubb,
H. Chin,
and
D. L. Garbers.
The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family.
Cell
58:
1155-1162,
1989[Web of Science][Medline].
21.
Sundler, F.,
G. Bottcher,
E. Ekblad,
and
R. Hakanson.
The neuroendocrine system of the gut.
Acta Oncologica
28:
303-314,
1989[Web of Science][Medline].
22.
Tallerico-Melnyk, T.,
C. C. Yip,
and
V. M. Watt.
Widespread co-localization of mRNAs encoding the guanylate cyclase-coupled natriuretic peptide receptors in rat tissues.
Biochem. Biophys. Res. Commun.
189:
610-616,
1992[Web of Science][Medline].
23.
Varro, A.,
and
G. J. Dockray.
Post-translational processing of progastrin: inhibition of cleavage, phosphorylation and sulphation by brefeldin A.
Biochem. J.
295:
813-819,
1993.
24.
Verburg, K. M.,
R. H. Freeman,
J. O. Davis,
D. Villarreal,
and
R. C. Vari.
Control of atrial natriuretic factor release in conscious dogs.
Am. J. Physiol. Regulatory Integrative Comp. Physiol.
251:
R947-R956,
1986.
25.
Vesely, D. L.
Atrial Natriuretic Hormones. Englewood Cliffs, NJ: Prentice Hall, 1992, p. 1-256.
26.
Vesely, D. L.,
and
A. T. Giordano.
Food intake and body positional change alter the circadian rhythm of atrial natriuretic peptides excretion into human urine.
Chronobiol. Int.
8:
373-384,
1991[Web of Science][Medline].
27.
Vuolteenaho, O.,
O. Arjama,
O. Vakkuri,
T. Madsniemi,
L. Nikkila,
J. Kangas,
J. Puurunen,
H. Ruskoaho,
and
J. Leppaluoto.
Atrial natriuretic peptide (ANP) in rat gastrointestinal tract.
FEBS Lett.
233:
79-82,
1988[Web of Science][Medline].
28.
Weber, W.,
W. Fischli,
E. Hochuli,
E. Kupfer,
and
E. K. Weibel.
Anantin-a peptide antagonist of the atrial natriuretic factor (ANF). I. Producing organism, fermentation, isolation and biological activities.
J. Antibiot. (Tokyo)
44:
164-171,
1991[Medline].
29.
Wong, H.,
W. D. Anderson,
T. Cheng,
and
K. T. Riabowol.
Monitoring mRNA expression by polymerase chain reaction: the primer-dropping method.
Analyt. Biochem.
223:
251-258,
1994.
30.
Wu, S. V.,
K. Sumii,
A. Tari,
M. Sumii,
and
J. H. Walsh.
Regulation of rat antral gastrin and somatostatin gene expression during starvation and after refeeding.
Gastroenterology
101:
1552-1558,
1991[Web of Science][Medline].
31.
Yamanaka, M.,
B. Greenberg,
L. Johnson,
J. Seilhamer,
M. Brewer,
T. Friedemann,
J. Miller,
S. Atlas,
J. Laragh,
J. Lewicki,
and
J. Fiddes.
Cloning and sequence analysis of the cDNA for the rat atrial natriuretic factor precursor.
Nature
309:
719-722,
1984[Medline].
This article has been cited by other articles:
![]() |
M. E. Sabbatini, M. S. Vatta, C. A. Davio, and L. G. Bianciotti Atrial natriuretic factor negatively modulates secretin intracellular signaling in the exocrine pancreas Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G349 - G357. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Sabbatini, A. Villagra, C. A. Davio, M. S. Vatta, B. E. Fernandez, and L. G. Bianciotti Atrial natriuretic factor stimulates exocrine pancreatic secretion in the rat through NPR-C receptors Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G929 - G937. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Gower Jr, S. Premaratne, R. W. McCuen, A. Arimura, Q. McAfee, and M. L. Schubert Gastric atrial natriuretic peptide regulates endocrine secretion in antrum and fundus of human and rat stomach Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G638 - G645. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Gower Jr., J. R. Dietz, R. W. McCuen, P. J. Fabri, E. A. Lerner, and M. L. Schubert Regulation of atrial natriuretic peptide secretion by cholinergic and PACAP neurons of the gastric antrum Am J Physiol Gastrointest Liver Physiol, January 1, 2003; 284(1): G68 - G74. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Vesely, W. R. Gower Jr., G. Perez-Lamboy, R. M. Overton, L. Graddy, and D. L. Vesely Evidence for an Atrial Natriuretic Peptide-Like Gene in Plants Experimental Biology and Medicine, January 1, 2001; 226(1): 61 - 65. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |